Strategic Initiative

Slingshot members are tracking this corporate initiative:

Dermavant Sciences Licenses Portola's (PTLA) Cerdulatinib for Topical Non-Cancer Applications

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
PTLA

100%
Dermavant Sciences

100%
Slingshot Insights Explained
Strategic Initiative Date
Announcement Date:
Dec 21, 2016
Projected Implementation:
Q1, 2017
Relevance Tracked Until:
Q1, 2019
Related Projects Image
  • Don’t see a project related to the strategic initiative you care about?

Related Keywords License Agreement, Cerdulatinib, Topical, Non-cancer Applications